Enhanced recovery after surgery pathways and postoperative gastrointestinal function in colorectal cancer: A prospective cohort study

Table 1 General data for patients

Indicators	Experimental group (n = 61)	Control group (n = 61)	χ2/t	P value
Age (years)	58.32 ± 9.41	59.17 ± 9.08	0.508	0.613
Sex (male/female)	35/26	36/25	0.034	0.854
Body weight (kg)	66.42 ± 9.37	67.15 ± 8.95	0.440	0.661
Height (cm)	167.82 ± 6.41	168.37 ± 6.12	0.485	0.629
BMI (kg/m2)	23.61 ± 2.58	23.74 ± 2.51	0.282	0.778
Hypertension, n (%)	12 (19.7)	13 (21.3)	0.050	0.823
Diabetes, n (%)	9 (14.8)	8 (13.1)	0.068	0.794
Clinical staging of tumors (II/III)	27/34	28/33	0.033	0.856
Surgery time (min)	163.45 ± 25.61	165.28 ± 26.13	0.391	0.697
Amount of bleeding (mL)	162.31 ± 41.28	165.19 ± 42.17	0.381	0.704
ASA score (I/II/III)	12/36/13	13/35/13	0.054	0.973
Hb pre-surgery (g/L)	128.52 ± 12.61	127.41 ± 12.37	0.491	0.625
Hb 3 days after surgery (g/L)	116.37 ± 11.28	115.42 ± 11.95	0.452	0.652
Hb 7 days after surgery (g/L)	121.42 ± 10.96	120.35 ± 11.27	0.532	0.596
ALB pre-surgery (g/L)	39.18 ± 4.26	38.92 ± 4.11	0.343	0.732
ALB 3 days after surgery (g/L)	35.27 ± 3.81	35.11 ± 3.74	0.234	0.815
ALB 7 days after surgery (g/L)	37.42 ± 3.65	37.11 ± 3.58	0.474	0.637
Cr pre-surgery (mol/L)	72.41 ± 10.18	73.05 ± 10.32	0.345	0.731
Cr 3 days after surgery (mol/L)	74.16 ± 10.27	74.92 ± 10.15	0.411	0.682
Cr 7 days after surgery (mol/L)	71.84 ± 9.95	72.36 ± 10.12	0.286	0.775

BMI: Body mass index; ASA: Association of Anesthesiologist; Hb: Hemoglobin; ALB: Albumin; Cr: Creatinine.